RenovoRx (RNXT) Change in Cash (2020 - 2026)
RenovoRx (RNXT) posted Change in Cash of $5.3 million for Q1 2026, up 276.75% sequentially from -$3.0 million in Q4 2025, and down 28.14% YoY from $7.4 million in Q1 2025.
RenovoRx (RNXT) Change in Cash (2020 - 2026) Analysis & Trends
RenovoRx has reported Change in Cash for 7 years, with the latest figure at $5.3 million in Q1 2026.
- Quarterly Change in Cash fell 28.14% year-over-year to $5.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.2 million (down 121.78% YoY) and the FY2025 annual result came in at -$130000.0, down 102.17% from the prior year.
- Change in Cash advanced to $5.3 million in Q1 2026 per RNXT's latest filing, from -$3.0 million in the prior quarter.
- Over five years, Change in Cash peaked at $7.4 million in Q1 2025 and troughed at -$10.4 million in Q2 2022.
- A 5-year average of -$166470.6 and a median of -$2.1 million in 2023 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 1537.78% in 2022, then jumped 581.44% in 2024.
- Over 5 years, Change in Cash stood at $1.3 million in 2022, then slumped by 258.17% to -$2.1 million in 2023, then fell by 17.34% to -$2.4 million in 2024, then dropped by 25.36% to -$3.0 million in 2025, then jumped by 276.75% to $5.3 million in 2026.
- According to Business Quant data, Change in Cash over the past three periods registered $5.3 million, -$3.0 million, and -$2.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | RenovoRx | 62.20 Mn | 62.20 Mn | 766,000.00 | -2.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.88 Mn |
| Mar 31, 2026 | 5.34 Mn |
| Dec 31, 2025 | -3.02 Mn |
| Sep 30, 2025 | -2.27 Mn |
| Jun 30, 2025 | -2.27 Mn |
| Mar 31, 2025 | 7.43 Mn |
| Dec 31, 2024 | -2.41 Mn |
| Sep 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | 7.35 Mn |
| Mar 31, 2024 | 3.22 Mn |
| Dec 31, 2023 | -2.05 Mn |
| Sep 30, 2023 | -2.73 Mn |
| Jun 30, 2023 | 2.23 Mn |
| Mar 31, 2023 | -668,000.00 |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 324,000.00 |
| Jun 30, 2022 | -10.35 Mn |
| Mar 31, 2022 | -2.07 Mn |
| Dec 31, 2021 | -2.53 Mn |
| Sep 30, 2021 | 16.17 Mn |